TrialGynecologic oncology2014

The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: a gynecologic Oncology Group study.

Amanda Nickles Fader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.